|
1
|
Sant M, Minicozzi P, Mounier M, Anderson
LA, Brenner H, Holleczek B, Marcos-Gragera R, Maynadié M, Monnereau
A, Osca-Gelis G, et al: Survival for haematological malignancies in
Europe between 1997 and 2008 by region and age: Results of
EUROCARE-5, a population-based study. Lancet Oncol. 15:931–942.
2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gratwohl A, Baldomero H, Aljurf M,
Pasquini MC, Bouzas LF, Yoshimi A, Szer J, Lipton J, Schwendener A,
Gratwohl M, et al: Hematopoietic stem cell transplantation: A
global perspective. JAMA. 303:1617–1624. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gooley TA, Chien JW, Pergam SA, Hingorani
S, Sorror ML, Boeckh M, Martin PJ, Sandmaier BM, Marr KA, Appelbaum
FR, et al: Reduced mortality after allogeneic hematopoietic-cell
transplantation. N Engl J Med. 363:2091–2101. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mo XD, Xu LP, Liu DH, Zhang XH, Chen H,
Chen YH, Han W, Wang Y, Wang FR, Wang JZ, et al: Heart failure
after allogeneic hematopoietic stem cell transplantation. Int J
Cardiol. 167:2502–2506. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Shen MZ, Li JX, Zhang XH, Xu LP, Wang Y,
Liu KY, Huang XJ, Hong SD and Mo XD: Meta-Analysis of Interleukin-2
Receptor Antagonists as the Treatment for Steroid-Refractory Acute
Graft-Versus-Host Disease. Front Immunol. 12(749266)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Shen MZ, Hong SD, Wang J, Zhang XH, Xu LP,
Wang Y, Yan CH, Chen H, Chen YH, Han W, et al: A predicted model
for refractory/recurrent cytomegalovirus infection in acute
leukemia patients after haploidentical hematopoietic stem cell
transplantation. Front Cell Infect Microbiol.
12(862526)2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Liu SN, Zhang XH, Xu LP, Wang Y, Yan CH,
Chen H, Chen YH, Han W, Wang FR, Wang JZ, et al: Prognostic factors
and long-term follow-up of basiliximab for steroid-refractory acute
graft-versus-host disease: Updated experience from a large-scale
study. Am J Hematol. 95:927–936. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Fan S, Huo WX, Yang Y, Shen MZ and Mo XD:
Efficacy and safety of ruxolitinib in steroid-refractory
graft-versus-host disease: A meta-analysis. Front Immunol.
13(954268)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ferreyro BL, Scales DC, Wunsch H, Cheung
MC, Gupta V, Saskin R, Thyagu S and Munshi L: Critical illness in
patients with hematologic malignancy: A population-based cohort
study. Intensive Care Med. 47:1104–1114. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Soubani AO, Kseibi E, Bander JJ, Klein JL,
Khanchandani G, Ahmed HP and Guzman JA: Outcome and prognostic
factors of hematopoietic stem cell transplantation recipients
admitted to a medical ICU. Chest. 126:1604–1611. 2004.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Azoulay E, Mokart D, Pène F, Lambert J,
Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Laisne LM,
et al: Outcomes of critically ill patients with hematologic
malignancies: prospective multicenter data from France and
Belgium-a groupe de recherche respiratoire en réanimation
onco-hématologique study. J Clin Oncol. 31:2810–2818.
2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Grgic Medic M, Gornik I and Gasparovic V:
Hematologic malignancies in the medical intensive care
unit-Outcomes and prognostic factors. Hematology. 20:247–253.
2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cuthbertson BH, Rajalingam Y, Harrison S
and McKirdy F: The outcome of haematological malignancy in scottish
intensive care units. J Intensive Care Soc. 9:135–140. 2008.
|
|
14
|
Yeo CD, Kim JW, Kim SC, Kim YK, Kim KH,
Kim HJ, Lee S and Rhee CK: Prognostic factors in critically ill
patients with hematologic malignancies admitted to the intensive
care unit. J Crit Care. 27:739 e1–e6. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Liu J, Cheng Q, Yang Q, Li X, Shen X,
Zhang L, Liu Z and Khoshnood K: Prognosis-related factors in
intensive care unit (ICU) patients with hematological malignancies:
A retrospective cohort analysis in a Chinese population.
Hematology. 20:494–503. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Irie H, Otake T, Kawai K, Hino M, Namazu
A, Shinjo Y and Yamashita S: Prognostic factors in critically ill
patients with hematological malignancy admitted to the general
intensive care unit: a single-center experience in Japan. J Anesth.
31:736–743. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bird GT, Farquhar-Smith P, Wigmore T,
Potter M and Gruber PC: Outcomes and prognostic factors in patients
with haematological malignancy admitted to a specialist cancer
intensive care unit: A 5 yr study. Br J Anaesth. 108:452–459.
2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Desprez C, Kouatchet A, Marchand T, Mear
JB, Tadié JM, Peterlin P, Chevalier P, Canet E, Couturier MA,
Guillerm G, et al: Outcome of patients with newly diagnosed AML
admitted to the ICU, including preemptive admission-a multi-center
study. Ann Hematol. 102:1383–1393. 2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lueck C, Tzalavras A, Wohlfarth P, Meedt
E, Kiehl M, Turki AT, Hoeper MM, Eder M, Cserna J, Buchtele N, et
al: Impact of chronic graft-versus-host-disease on intensive care
outcome in allogeneic hematopoietic stem cell recipients. Bone
Marrow Transplant. 58:303–310. 2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Díaz-Lagares C, Fox L, García-Roche A,
Santafe M, Romera I, Barba P, Pacheco A, Roldán E, Plata-Menchaca
E, Roca O, et al: Sequential organ failure assessment score and the
need for organ support predict mortality in allogeneic stem cell
transplant patients admitted to the intensive care unit. Transplant
Cell Ther. 27:865.e1–865.e7. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mokart D, Granata A, Crocchiolo R, Sannini
A, Chow-Chine L, Brun JP, Bisbal M, Faucher M, Faucher C, Blache
JL, et al: Allogeneic hematopoietic stem cell transplantation after
reduced intensity conditioning regimen: Outcomes of patients
admitted to intensive care unit. J Crit Care. 30:1107–1113.
2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Nassar AP Jr, Archanjo LVF, Ranzani OT,
Zampieri FG, Salluh JIF, Cavalcanti GFR, Moreira CEN, Viana WN,
Costa R, Melo UO, et al: Characteristics and outcomes of autologous
hematopoietic stem cell transplant recipients admitted to intensive
care units: A multicenter study. J Crit Care.
71(154077)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gournay V, Dumas G, Lavillegrand JR,
Hariri G, Urbina T, Baudel JL, Ait-Oufella H, Maury E, Brissot E,
Legrand O, et al: Outcome of allogeneic hematopoietic stem cell
transplant recipients admitted to the intensive care unit with a
focus on haploidentical graft and sequential conditioning regimen:
Results of a retrospective study. Ann Hematol. 100:2787–2797.
2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
McDonagh TA, Metra M, Adamo M, Gardner RS,
Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, et
al: 2021 ESC Guidelines for the diagnosis and treatment of acute
and chronic heart failure. Eur Heart J. 42:3599–3726.
2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Rhodes A, Evans LE, Alhazzani W, Levy MM,
Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally
ME, et al: Surviving sepsis campaign: International guidelines for
management of sepsis and septic shock: 2016. Intensive Care Med.
43:304–377. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Palevsky PM, Liu KD, Brophy PD, Chawla LS,
Parikh CR, Thakar CV, Tolwani AJ, Waikar SS and Weisbord SD: KDOQI
US commentary on the 2012 KDIGO clinical practice guideline for
acute kidney injury. Am J Kidney Dis. 61:649–672. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Flamm SL, Yang YX, Singh S and Falck-Ytter
YT: AGA Institute Clinical Guidelines Committee. American
gastroenterological association institute guidelines for the
diagnosis and management of acute liver failure. Gastroenterology.
152:644–647. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bajaj JS, O'Leary JG, Lai JC, Wong F, Long
MD, Wong RJ and Kamath PS: Acute-on-Chronic liver failure clinical
guidelines. Am J Gastroenterol. 117:225–252. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Murugan R, Hoste E, Mehta RL, Samoni S,
Ding X, Rosner MH, Kellum JA and Ronco C: Acute Disease Quality
Initiative (ADQI) Consensus Group. Precision fluid management in
continuous renal replacement therapy. Blood Purif. 42:266–278.
2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Abe T, Matsuo H, Abe R, Abe S, Asada H,
Ashida A, Baba A, Eguchi K, Eguchi Y, Endo Y, et al: The Japanese
Society for Apheresis clinical practice guideline for therapeutic
apheresis. Ther Apher Dial. 25:728–876. 2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Nava S and Hill N: Non-invasive
ventilation in acute respiratory failure. Lancet. 374:250–259.
2009.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Rochwerg B, Brochard L, Elliott MW, Hess
D, Hill NS, Nava S and Navalesi P: Members Of The Steering
Committee. Antonelli M, Brozek J, et al: Official ERS/ATS clinical
practice guidelines: Noninvasive ventilation for acute respiratory
failure. Eur Respir J. 50(1602426)2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Baden LR, Swaminathan S, Angarone M,
Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM,
Freifeld AG, et al: Prevention and treatment of cancer-related
infections, version 2.2016, NCCN clinical practice guidelines in
oncology. J Natl Compr Canc Netw. 14:882–913. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gauzit R, Castan B, Bonnet E, Bru JP,
Cohen R, Diamantis S, Faye A, Hitoto H, Issa N, Lebeaux D, et al:
Anti-infectious treatment duration: The SPILF and GPIP French
guidelines and recommendations. Infect Dis Now. 51:114–139.
2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Azoulay E, Schellongowski P, Darmon M,
Bauer PR, Benoit D, Depuydt P, Divatia JV, Lemiale V, van Vliet M,
Meert AP, et al: The Intensive Care Medicine research agenda on
critically ill oncology and hematology patients. Intensive Care
Med. 43:1366–1382. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Hill QA: Intensify, resuscitate or
palliate: Decision making in the critically ill patient with
haematological malignancy. Blood Rev. 24:17–25. 2010.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Blot F, Guiguet M, Nitenberg G, Leclercq
B, Gachot B and Escudier B: Prognostic factors for neutropenic
patients in an intensive care unit: respective roles of underlying
malignancies and acute organ failures. Eur J Cancer. 33:1031–1037.
1997.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Benoit DD, Vandewoude KH, Decruyenaere JM,
Hoste EA and Colardyn FA: Outcome and early prognostic indicators
in patients with a hematologic malignancy admitted to the intensive
care unit for a life-threatening complication. Crit Care Med.
31:104–112. 2003.PubMed/NCBI View Article : Google Scholar
|
|
39
|
van der Heiden PLJ, Arbous MS, van Beers
EJ, van den Bergh WM, le Cessie S, Demandt AMP, Eefting M, Hess C,
Kusadasi N, Marijt WAF, et al: Predictors of short-term and
long-term mortality in critically ill patients admitted to the
intensive care unit following allogeneic stem cell transplantation.
Bone Marrow Transplant. 54:418–424. 2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Pène F, Aubron C, Azoulay E, Blot F,
Thiéry G, Raynard B, Schlemmer B, Nitenberg G, Buzyn A, Arnaud P,
et al: Outcome of critically ill allogeneic hematopoietic stem-cell
transplantation recipients: A reappraisal of indications for organ
failure supports. J Clin Oncol. 24:643–649. 2006.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Akahoshi Y, Kanda J, Gomyo A, Hayakawa J,
Komiya Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, et al:
Risk factors and impact of secondary failure of platelet recovery
after allogeneic stem cell transplantation. Biol Blood Marrow
Transplant. 22:1678–1683. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Ivanov V, Faucher C, Mohty M, Bilger K,
Ladaique P, Sainty D, Arnoulet C, Chabannon C, Vey N, Camerlo J, et
al: Early administration of recombinant erythropoietin improves
hemoglobin recovery after reduced intensity conditioned allogeneic
stem cell transplantation. Bone Marrow Transplant. 36:901–906.
2005.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hemauer SJ, Kingeter AJ, Han X, Shotwell
MS, Pandharipande PP and Weavind LM: Daily lowest hemoglobin and
risk of organ dysfunctions in critically Ill patients. Crit Care
Med. 45:e479–e484. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Gündoğan K, Akbudak İH, Hancı P, Halaçlı
B, Temel Ş, Güllü Z, İnci K, Bilir Y, Bozkurt FT, Yıldırım F, et
al: Clinical outcomes and independent risk factors for 90-day
mortality in critically Ill patients with respiratory failure
infected with SARS-CoV-2: A multicenter study in turkish intensive
care units. Balkan Med J. 38:296–303. 2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Eisenberg PR, Jaffe AS, Stump DC, Collen D
and Bovill EG: Validity of enzyme-linked immunosorbent assays of
cross-linked fibrin degradation products as a measure of clot
lysis. Circulation. 82:1159–1168. 1990.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Toh JM, Ken-Dror G, Downey C and Abrams
ST: The clinical utility of fibrin-related biomarkers in sepsis.
Blood Coagul Fibrinolysis. 24:839–843. 2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Fei A, Lin Q, Liu J, Wang F, Wang H and
Pan S: The relationship between coagulation abnormality and
mortality in ICU patients: A prospective, observational study. Sci
Rep. 5(9391)2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Crone KR, Lee KS and Kelly DL Jr:
Correlation of admission fibrin degradation products with outcome
and respiratory failure in patients with severe head injury.
Neurosurgery. 21:532–536. 1987.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Hertenstein B, Stefanic M, Schmeiser T,
Scholz M, Göller V, Clausen M, Bunjes D, Wiesneth M, Novotny J and
Kochs M: Cardiac toxicity of bone marrow transplantation:
Predictive value of cardiologic evaluation before transplant. J
Clin Oncol. 12:998–1004. 1994.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Szydlo R, Goldman JM, Klein JP, Gale RP,
Ash RC, Bach FH, Bradley BA, Casper JT, Flomenberg N, Gajewski JL,
et al: Results of allogeneic bone marrow transplants for leukemia
using donors other than HLA-identical siblings. J Clin Oncol.
15:1767–1777. 1997.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Howard CA, Fernandez-Vina MA, Appelbaum
FR, Confer DL, Devine SM, Horowitz MM, Mendizabal A, Laport GG,
Pasquini MC and Spellman SR: Recommendations for donor human
leukocyte antigen assessment and matching for allogeneic stem cell
transplantation: consensus opinion of the Blood and Marrow
Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow
Transplant. 21:4–7. 2015.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Yang B, Yu R, Cai L, Bin Guo, Chen H,
Zhang H, He P and Lu X: Haploidentical versus matched donor stem
cell transplantation for patients with hematological malignancies:
A systemic review and meta-analysis. Bone Marrow Transplantation.
54:99–122. 2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Rashidi A, Hamadani M, Zhang MJ, Wang HL,
Abdel-Azim H, Aljurf M, Assal A, Bajel A, Bashey A, Battiwalla M,
et al: Outcomes of haploidentical vs matched sibling
transplantation for acute myeloid leukemia in first complete
remission. Blood Adv. 3:1826–1836. 2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Ghosh N, Karmali R, Rocha V, Ahn KW,
DiGilio A, Hari PN, Bachanova V, Bacher U, Dahi P, de Lima M, et
al: Reduced-Intensity transplantation for lymphomas using
haploidentical related donors versus HLA-Matched Sibling Donors: A
center for international blood and marrow transplant research
analysis. J Clin Oncol. 34:3141–3149. 2016.PubMed/NCBI View Article : Google Scholar
|
